President Trump made his play over protectionist policies during his campaign for the White House but Shein believes it can keep prices low with a fair playing ground.
Weight-loss drug developer Metsera is targeting an up to $1.78 billion valuation in its initial public offering, the ARCH Venture Partners-backed biotech company said on Monday. New York City-based ...